Epicardial Adipose Tissue and Cardiac Dysfunction in Heart Failure With Preserved Ejection Fraction: Challenging a Complex Conundrum
Authors:
- Yoran CrumYCYoran Crum
- Thomas M. GorterTGThomas M. Gorter
Open Access
- 9 March 2026
- journal article
- Published by Elsevier in Journal of Cardiac Failure - Intersections
- Vol. 2 (4) , 305-307
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- The Adipokine Hypothesis of Heart Failure With a Preserved Ejection FractionJACC, 2025
- Epicardial Adipose Tissue, Functional Status, and Invasive Hemodynamics in Heart Failure With Preserved Ejection FractionJACC: Advances, 2025
- Epicardial Adipose Tissue and Pericardial Constraint in Heart Failure with Preserved Ejection FractionESC Heart Failure, 2024
- Obesity in Heart Failure with Preserved Ejection Fraction: Insights from the REDUCE LAP-HF II TrialEuropean Journal of Heart Failure, 2023
- The Value of Echocardiographic Measurement of Epicardial Adipose Tissue in Heart Failure PatientsESC Heart Failure, 2022
- Epicardial Adipose Tissue Accumulation Confers Atrial Conduction AbnormalityJACC, 2020
- Epicardial Adipose Tissue and Invasive Hemodynamics in Heart Failure With Preserved Ejection FractionJACC: Heart Failure, 2020
- Hemodynamic and Functional Impact of Epicardial Adipose Tissue in Heart Failure With Preserved Ejection FractionJACC: Heart Failure, 2020
- Epicardial Adipose Tissue May Mediate Deleterious Effects of Obesity and Inflammation on the MyocardiumJACC, 2018
- Human Epicardial Adipose Tissue Is a Source of Inflammatory MediatorsCirculation, 2003